Abstract
Objective: The aims of the study were to compare the risk levels of exposed drugs during pregnancy with regard to United States Food and Drug Administration (FDA), Australian Drug Evaluation Committee (ADEC) and Teratogen Information System (TERIS) risk categories, and to determine the outcomes of FDA risk category based decisions on the course of pregnancy in pregnant women who applied to Dokuz Eylul University (DEU) Teratogenity Information Service (TIS). Material and Methods: In this cross-sectional study, 220 pregnant women were enrolled who referred to DEU TIS for a teratogenity risk evaluation due to drug exposure during their pregnancies. Demographics, medical history, time and duration of the exposed drugs were recorded. Drugs exposed during pregnancy were divided into two categories as high or low risk. A drug that was exposed during pregnancy of the highest risk according to FDA was taken into consideration for the evaluation of the outcomes of the pregnancy. Additionally, FDA, TERIS and ADEC risk categories which were classified as
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
